Mark Stevens
Impact in
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Otorhinolaryngology top 5%
Papers in
- Surgery 12
- Testicular diseases and treatments 5
- Management of metastatic bone disease 3
-
- Lung Cancer Diagnosis and Treatment 4
- Co-authors
- BW Goodell (1 shared paper)Nancy Flournoy (1 shared paper)Thomas Ed (1 shared paper)A Fefer (1 shared paper)GE Sale (1 shared paper)R Storb (1 shared paper)Clift Ra (1 shared paper)JE Sanders (1 shared paper)
- Journals
- Radiation Oncology (2 papers)BMC Cancer (2 papers)Cancers (2 papers)Brachytherapy (1 paper)Head & Neck (1 paper)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark Stevens
36 papers receiving 1.2k citations
Mark Stevens's Hit Papers
Peers
Comparison fields: 5 of 89
- Hematology 592
- Otorhinolaryngology 55
- Genetics 132
- Oncology 311
- Immunology 159
Countries citing papers authored by Mark Stevens
This map shows the geographic impact of Mark Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stevens more than expected).
Fields of papers citing papers by Mark Stevens
This network shows the impact of papers produced by Mark Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stevens. The network helps show where Mark Stevens may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Stevens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation Hit paper breakdown → | 1977 | 755 |
| 2 | 2016 | 59 | |
| 3 | 2021 | 45 | |
| 4 | 1990 | 38 | |
| 5 | 2021 | 34 | |
| 6 | 2019 | 33 | |
| 7 | 1995 | 31 | |
| 8 | 2020 | 27 | |
| 9 | 2015 | 25 | |
| 10 | 2014 | 24 | |
| 11 | 2017 | 23 | |
| 12 | 1994 | 20 | |
| 13 | 2015 | 19 | |
| 14 | 2010 | 19 | |
| 15 | 2021 | 18 | |
| 16 | 2018 | 15 | |
| 17 | 1993 | 14 | |
| 18 | 2020 | 12 | |
| 19 | 2019 | 12 | |
| 20 | 1996 | 12 |
About Mark Stevens
Mark Stevens is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Obstetrics and Gynecology and Reproductive Medicine, having authored 38 papers that have together received 1.3k indexed citations. Recurring topics across this work include Testicular diseases and treatments (5 papers), Lung Cancer Diagnosis and Treatment (4 papers), Endometrial and Cervical Cancer Treatments (4 papers), Head and Neck Cancer Studies (3 papers), Advanced Radiotherapy Techniques (3 papers), Management of metastatic bone disease (3 papers), Effects of Radiation Exposure (3 papers) and Urologic and reproductive health conditions (2 papers). The work is most often cited by research in Hematology (592 citations), Otorhinolaryngology (55 citations), Genetics (132 citations), Oncology (311 citations) and Immunology (159 citations). Mark Stevens has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include BW Goodell, Nancy Flournoy, Thomas Ed, A Fefer, GE Sale, R Storb, Clift Ra, JE Sanders, Jack W. Singer and PL Weiden. Their work appears in journals such as Radiation Oncology, BMC Cancer, Cancers, Brachytherapy and Head & Neck.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.